Organization: Health Canada
Year: 2022
Month: March
Request Number: A-2021-001922
Request Summary: Correspondence relating to any abbreviated new drug submission filed since June 1, 2021, in which the Canadian reference product is XULTOPHY.
Disposition: No records exist
Number of pages: 0